<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>POTASSIUM PHOSPHATES- potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution </strong><br>Fresenius Kabi USA, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Potassium Phosphates Injection USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="fd954f90-f894-4b02-946f-fa551e09cf40"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold"><span class="Emphasis">3 mmol Phosphate/mL and 4.4 mEq Potassium/mL</span></span></p>
<p><span class="Italics"><span class="Emphasis">FOR INTRAVENOUS USE ONLY MUST BE DILUTED PRIOR TO ADMINISTRATION</span></span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="edff5d45-25ed-4acf-bf42-6ed5f444ef9c"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Potassium Phosphates Injection, USP is a sterile, nonpyrogenic, concentrated solution containing a mixture of mono and dibasic potassium phosphate in Water for Injection q.s.  It must be diluted prior to administration.</p>
<p>7.4 mOsmol/mL     pH 6.2 to 6.8</p>
<p>Each mL of the solution consists of two phosphate salts provided as follows:</p>
<table><tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Ingredient(s)</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First">Phosphate     </p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First">Potassium  </p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Monobasic Potassium Phosphate – 224 mg     </p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">285 mg</p>
<p>(3 mmol)</p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<p class="First">170 mg</p>
<p>(4.4 mEq)</p>
</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">Dibasic Potassium Phosphate – 236 mg</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First">–</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><p class="First">–</p></td>
</tr>
</tbody></table>
<p>The solution contains no bacteriostatic agent or other preservatives.  Unused portions should be discarded.</p>
<p>The solution is intended to provide phosphate ion; (PO<span class="Sub">4</span><span class="Sup">3-</span>) for addition to large volume infusion fluids for intravenous use.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="d740c2bc-6f1d-4405-a156-17513e513f97"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Phosphorus in the form of organic and <span class="product-label-link" type="condition" conceptid="4106483" conceptname="P">inorganic phosphate</span> has a variety of important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues.  It exerts a modifying influence on the steady state of calcium levels, a buffering effect on acid-base equilibrium and a primary role in the renal excretion of hydrogen ion.</p>
<p>Phosphorus is present in plasma and other extracellular fluid, in cell membranes and intracellular fluid, as well as in collagen and bone tissues.  Phosphate in the extracellular fluid is primarily in inorganic form, and plasma-levels may vary somewhat with age.  The ratio of disodium phosphate and monosodium phosphate in the extracellular fluid is 4:1 (80%:20%) at the normal pH of 7.4.  This buffer ratio varies with the pH, but owing to its relatively low concentration, it contributes little to the buffering capacity of the extracellular fluids.</p>
<p>Phosphate, present in large amounts in erythrocytes and other tissue cells, plays a significant intracellular role in the synthesis of high energy organic phosphates.</p>
<p><span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">Hypophosphatemia</span> should be avoided during periods of total parenteral nutrition, or other lengthy periods of intravenous infusions.  Serum phosphate levels should be regularly monitored, and appropriate amounts of phosphate should be added to the infusions to maintain normal serum phosphate levels.  Intravenous infusion of <span class="product-label-link" type="condition" conceptid="4106483" conceptname="P">inorganic phosphate</span> may be accompanied by a decrease in the serum level and urinary excretion of calcium.  Intravenously infused phosphate not taken up by the tissues is excreted almost entirely in the urine.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="eccab8d4-2816-4941-ba7a-49fe5fa2971a"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Potassium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids to prevent or correct <span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">hypophosphatemia</span> in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte of nutrient solutions.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="b7a8cafa-93ec-4a49-bd8d-e20be6bb532d"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Potassium phosphates is contraindicated in diseases where high potassium, high phosphate or low calcium levels may be encountered.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="cb296d4e-c58e-444e-b4b2-fbc354990bf7"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold"><span class="Emphasis">Potassium phosphates must be diluted before use.</span></span></p>
<p>WARNING: This product contains aluminum that may be toxic.  Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired.  Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.</p>
<p>Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity.  Tissue loading may occur at even lower rates of administration.</p>
<p>To avoid potassium or phosphate <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>, infuse solutions containing potassium phosphates slowly.  In patients with severe renal or <span class="product-label-link" type="condition" conceptid="193984" conceptname="Adrenal hypofunction">adrenal insufficiency</span>, administration of potassium phosphates may cause potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>, infusing high concentrations of phosphate may cause <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span>, and calcium levels should be monitored.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="e876a6dd-a1b6-4324-b52b-94fc7b0d6ae4"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Phosphate replacement therapy with potassium phosphates should be guided primarily by the serum <span class="product-label-link" type="condition" conceptid="4106483" conceptname="P">inorganic phosphate</span> level and the limits imposed by the accompanying potassium (K+) ion.</p>
<p>High plasma concentrations of potassium may cause <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> through cardiac <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> or arrest.</p>
<p>Use with caution in the presence of cardiac disease, particularly in digitalized patients or in the presence of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="f0c24532-0b01-4edc-98ef-d2e8ef8c9fcc"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Adverse reactions involve the possibility of combined potassium and phosphate <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> from overdosage.  The signs and symptoms of potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4193951" conceptname="Flaccid paralysis">flaccid paralysis</span>, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">listlessness</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span> and heaviness of the legs, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, heartblock, electrocardiographic abnormalities such as disappearance of P waves, spreading and slurring of the <span class="product-label-link" type="condition" conceptid="4064625" conceptname="QRS complex feature">QRS complex</span> with development of a biphasic curve and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>.  Phosphate <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> results in a reduction of serum calcium, and the symptoms are those of <span class="product-label-link" type="condition" conceptid="380534" conceptname="Tetany">hypocalcemic tetany</span>, (see <span class="Bold"><span class="Emphasis">WARNINGS</span></span>).</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="fd8129a6-e24d-495b-b0c5-f561983c7ab4"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Potassium phosphates is administered intravenously only after dilution in a larger volume of fluid.  The dose and rate of administration are dependent upon the individual needs of the patient.  Serum potassium, inorganic phosphorus and calcium levels should be monitored as a guide to dosage.</p>
<p>Withdraw the calculated volume aseptically and transfer to appropriate intravenous fluid to provide the desired number of millimoles (mmol) of phosphate and milliequivalent (mEq) of Potassium (K+).</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="a2d01347-2f4b-4d69-9852-d394955622b3"></a><a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In the event of overdosage, discontinue infusions containing potassium phosphates immediately, and institute corrective therapy to restore depressed serum calcium and to reduce elevated serum potassium levels.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="cc0548cd-cb53-422c-a681-c123ec355df8"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Potassium Phosphates Injection, USP, 3 mmol/mL, packaged 25 per carton is available as follows:</p>
<table><tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Product   <br></span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">NDC                </span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First"> </p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">8605P</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-086-05    </p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">5 mL fill in a 10 mL single dose, flip-top vial.</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">8615P</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-086-15</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">15 mL fill in a 30 mL single dose, flip-top vial.</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">8650</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">63323-086-50</p></td>
<td class="Botrule Lrule Rrule Toprule" valign="top"><p class="First">50 mL a single dose, flip-top vial.</p></td>
</tr>
</tbody></table>
<p>The quantity of phosphate/mL is 285 mg and the quantity of potassium/mL is 170 mg.  This product is preservative free.  Any unused portion should be discarded.</p>
<p>Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="dc8d3aae-2e0e-4929-91e6-6dc7f473188b"></a><a name="section-12"></a><p></p>
<h1></h1>
<p class="First"><img alt="logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e7d6dfe1-d8ad-4daf-9c6a-5f42e3e19138&amp;name=potassium-phosphates-injection-usp-figure-1-fklogo.jpg"> </p>
<p>45809E</p>
<p>Revised: August 2013</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ad867e39-94d8-4d2f-b8d3-bb6aa39d5ca6"></a><a name="section-13"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Potassium Phosphates 50 mL Single Dose Vial</span></span></p>
<p><span class="Bold"><span class="Emphasis">NDC</span></span> 63323-086-50</p>
<p>8650</p>
<p><span class="Bold"><span class="Emphasis">Potassium Phosphates Injection, USP</span></span></p>
<p><span class="Bold"><span class="Emphasis">Phosphorus 150 mmol / 50 mL  (3 mmol/mL)</span></span></p>
<p><span class="Bold"><span class="Emphasis">Potassium 220 mEq / 50 mL  (4.4 mEq/mL)</span></span></p>
<p>For IV Use Only After Dilution</p>
<p><span class="Bold"><span class="Emphasis">50 mL</span></span> Single Dose Vial</p>
<p>Rx only</p>
<p>  </p>
<div class="Figure"><img alt="8650-vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e7d6dfe1-d8ad-4daf-9c6a-5f42e3e19138&amp;name=potassium-phosphates-injection-usp-figure-2-8650-vial.jpg"></div>
<br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POTASSIUM PHOSPHATES 		
					</strong><br><span class="contentTableReg">potassium phosphate, monobasic and potassium phosphate, dibasic injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63323-086</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, MONOBASIC</strong> (PHOSPHATE ION) </td>
<td class="formItem">POTASSIUM PHOSPHATE, MONOBASIC</td>
<td class="formItem">224 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, DIBASIC</strong> (PHOSPHATE ION) </td>
<td class="formItem">POTASSIUM PHOSPHATE, DIBASIC</td>
<td class="formItem">236 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63323-086-05</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:63323-086-15</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">15 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:63323-086-50</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 VIAL, SINGLE-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">08/08/2000</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Fresenius Kabi USA, LLC
							(608775388)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Fresenius Kabi USA, LLC</td>
<td class="formItem"></td>
<td class="formItem">023648251</td>
<td class="formItem">MANUFACTURE(63323-086)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>3d39f2fc-640b-468e-88d7-b9e8f7ae27d4</div>
<div>Set id: e7d6dfe1-d8ad-4daf-9c6a-5f42e3e19138</div>
<div>Version: 1</div>
<div>Effective Time: 20130918</div>
</div>
</div> <div class="DistributorName">Fresenius Kabi USA, LLC</div></p>
</body></html>
